Predicted to enable phospholipase binding activity and signaling receptor activity. Predicted to be involved in several processes, including negative regulation of phospholipase A2 activity; oxidative stress-induced premature senescence; and regulation of arachidonate secretion. Predicted to be located in cell surface and extracellular region. Predicted to be part of receptor complex. Predicted to be active in plasma membrane. Orthologous to human PLA2R1 (phospholipase A2 receptor 1).
RGD Description
Predicted to enable phospholipase binding activity and signaling receptor activity. Predicted to be involved in several processes, including negative regulation of phospholipase A2 activity; oxidative stress-induced premature senescence; and regulation of arachidonate secretion. Predicted to be located in cell surface and extracellular region. Predicted to be part of receptor complex. Predicted to be active in plasma membrane. Orthologous to human PLA2R1 (phospholipase A2 receptor 1); PARTICIPATES IN phagocytosis pathway; tuberculosis pathway; INTERACTS WITH 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine; 2,4-dinitrotoluene.